The Dry Eye Workup: Diagnosing in Three Steps

For years, diagnosing dry eye meant an inconsistent routine; surveys found clinicians using, on average, nine different tests. TFOS DEWS III replaced that drift with a short, repeatable, three-step pathway that any clinic can apply consistently (TFOS DEWS III, 2025, American Journal of Ophthalmology). The discipline matters more than any single instrument.

Step one: screen with the OSDI-6

The pathway opens with a symptom screen, because dry eye is by definition a symptomatic disease. The OSDI-6 is summed, and a total of four or more is a positive screen. It takes two to three minutes and can be completed in the waiting area.

Step two: confirm with one sign

A positive screen warrants confirmation with a single sign rather than a battery: either a non-invasive tear breakup time under ten seconds or elevated osmolarity. The two proved largely interchangeable in the population analysis underpinning the report, so requiring both adds cost and chair time without adding diagnostic yield.

Step three: never skip ocular surface staining

The single most important message is about staining. Ocular surface staining is the test that cannot be left out: relying on one sign without it misses a meaningful proportion of patients, while staining combined with one other sign approaches the full diagnosed population. Limiting to corneal staining alone roughly halves the yield.

Staining must be done properly and across all relevant surfaces: fluorescein for the cornea, lissamine green for the conjunctiva, and attention to the lid margin. To get a useful concentration of lissamine green, the strip is held in place for at least five seconds before instilling the drop; with fluorescein, the minimum volume that gives an even film works best.

From diagnosis to drivers

The same ordered sequence that confirms the diagnosis, tear meniscus height and blink rate, breakup time, redness and inflammatory markers, interferometry, lid expression, staining and meibography, also populates the driver-based subclassification that steers treatment. Severity is reported feature by feature; DEWS III is clear that there is no validated way to combine findings into a single composite score. A consolidated platform such as me-check® helps carry this load consistently in a busy clinic.

Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.